Waage A - Search Results

1

Potential value of pre-planned imaging of bone disease in multiple myeloma.

Gundesen MT, Asmussen JT, Schjesvold F, Vangsted AJ, Helleberg C, Haukås E, Silkjær T, Teodorescu EM, Jensen BA, Slørdahl TS, Nahi H, Waage A, Abildgaard N, Lund T; Nordic Myeloma Study Group. Gundesen MT, et al. Among authors: waage a. Blood Cancer J. 2023 Jul 7;13(1):105. doi: 10.1038/s41408-023-00880-0. Blood Cancer J. 2023. PMID: 37419876 Free PMC article. No abstract available.

2

Hepatocyte growth factor and its receptor c-met in multiple myeloma.

Börset M, Hjorth-Hansen H, Seidel C, Sundan A, Waage A. Börset M, et al. Among authors: waage a. Blood. 1996 Nov 15;88(10):3998-4004. Blood. 1996. PMID: 8916966 Free article.

3

Elevated serum concentrations of hepatocyte growth factor in patients with multiple myeloma. The Nordic Myeloma Study Group.

Seidel C, Børset M, Turesson I, Abildgaard N, Sundan A, Waage A. Seidel C, et al. Among authors: waage a. Blood. 1998 Feb 1;91(3):806-12. Blood. 1998. PMID: 9446640 Free article.

4

Marked osteoblastopenia and reduced bone formation in a model of multiple myeloma bone disease in severe combined immunodeficiency mice.

Hjorth-Hansen H, Seifert MF, Börset M, Aarset H, Ostlie A, Sundan A, Waage A. Hjorth-Hansen H, et al. Among authors: waage a. J Bone Miner Res. 1999 Feb;14(2):256-63. doi: 10.1359/jbmr.1999.14.2.256. J Bone Miner Res. 1999. PMID: 9933480 Free article.

5

Prognostic evaluation in multiple myeloma: an analysis of the impact of new prognostic factors.

Turesson I, Abildgaard N, Ahlgren T, Dahl I, Holmberg E, Hjorth M, Nielsen JL, Odén A, Seidel C, Waage A, Westin J, Wislöff F. Turesson I, et al. Among authors: waage a. Br J Haematol. 1999 Sep;106(4):1005-12. doi: 10.1046/j.1365-2141.1999.01651.x. Br J Haematol. 1999. PMID: 10520004 Free article.

6

Hepatocyte growth factor (HGF) induces interleukin-11 secretion from osteoblasts: a possible role for HGF in myeloma-associated osteolytic bone disease.

Hjertner O, Torgersen ML, Seidel C, Hjorth-Hansen H, Waage A, Børset M, Sundan A. Hjertner O, et al. Among authors: waage a. Blood. 1999 Dec 1;94(11):3883-8. Blood. 1999. PMID: 10572104 Free article.

7

Serum syndecan-1: a new independent prognostic marker in multiple myeloma.

Seidel C, Sundan A, Hjorth M, Turesson I, Dahl IM, Abildgaard N, Waage A, Borset M. Seidel C, et al. Among authors: waage a. Blood. 2000 Jan 15;95(2):388-92. Blood. 2000. PMID: 10627439 Free article. Clinical Trial.

8

High levels of soluble syndecan-1 in myeloma-derived bone marrow: modulation of hepatocyte growth factor activity.

Seidel C, Børset M, Hjertner O, Cao D, Abildgaard N, Hjorth-Hansen H, Sanderson RD, Waage A, Sundan A. Seidel C, et al. Among authors: waage a. Blood. 2000 Nov 1;96(9):3139-46. Blood. 2000. PMID: 11049995 Free article.

9

Bone morphogenetic protein-4 inhibits proliferation and induces apoptosis of multiple myeloma cells.

Hjertner O, Hjorth-Hansen H, Börset M, Seidel C, Waage A, Sundan A. Hjertner O, et al. Among authors: waage a. Blood. 2001 Jan 15;97(2):516-22. doi: 10.1182/blood.v97.2.516. Blood. 2001. PMID: 11154231 Free article.

10

Serum osteoprotegerin levels are reduced in patients with multiple myeloma with lytic bone disease.

Seidel C, Hjertner Ø, Abildgaard N, Heickendorff L, Hjorth M, Westin J, Nielsen JL, Hjorth-Hansen H, Waage A, Sundan A, Børset M; Nordic Myeloma Study Group. Seidel C, et al. Among authors: waage a. Blood. 2001 Oct 1;98(7):2269-71. doi: 10.1182/blood.v98.7.2269. Blood. 2001. PMID: 11568016 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

309 results

Search Page

Filters